StockData
International Stem Cell CORP logo

International Stem Cell CORP (ISCO) bonds

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

International Stem Cell reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in International Stem Cell's 10-Q for the period ended Feb 28, 2026

IssueAmount issued
Unsecured Non Convertible Promissory Note
Convertible
$2.35M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?